Nikita Shah, Executive Vice President at Amneal Pharmaceuticals, Inc. (AMRX), sold 235,324 shares at $9.50 ($2.3M) on 2025-08-25, disclosed to the SEC on 2025-08-25.
Open-market sale of $2.3M AMRX by Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.66 | 114,492 | $1.1M | 48.7% |
| 2 | $9.66 | 114,492 | $1.1M | 48.7% |
| 3 | $9.50 | 6,340 | $60K | 2.7% |
| Total | $9.66 avg | 235,324 | $2.3M | 100% |
| Filing → |
| AMRX | SELL | 2025-08-15 | $1.3M | — | Filing → |
| AMRX | SELL | 2025-08-13 | $904K | — | Filing → |
| AMRX | SELL | 2025-05-19 | $745K | — | Filing → |